Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis

By Migliore A.   Broccoli S.   Massafra U.   Bizzi E.   Frediani B.  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 467-473

Informa Healthcare

Access to resources Recommend Favorite

Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

By Bogado1 César E   Massari2 Fabio E   Zanchetta3 José R  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 447-457

Future Medicine

Access to resources Recommend Favorite

Treatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study

By Zanchetta José R.   Bogado Cesar E.   Cisari Carlo   Aslanidis Spyros   Greisen Hanna   Fox John   Lems Willem  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2627-2633

Informa Healthcare

Access to resources Recommend Favorite

Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women

By Adami Silvano  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3259-3274

Informa Healthcare

Access to resources Recommend Favorite

Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis

By Lasco A.   Catalano A.   Morabito N.   Gaudio A.   Basile G.   Trifiletti A.   Atteritano M.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 299-303

Springer Publishing Company

Access to resources Recommend Favorite